| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $524,850,312 ) (Continued on the next page) |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01NS078680 | Biophysical Basis of Functional Connectivity by MRI | 002 | 13 | NIH | 6/12/2024 | $608,775 |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AR063157 | Roles of Collagen and Water in the Fracture Resistance of Bone | 000 | 10 | NIH | 5/16/2024 | $424,125 |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R25DK096999 | Undergraduate Discovery Science Experience in Renal Biology and Disease | 004 | 13 | NIH | 5/16/2024 | $10,321 |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R25DK096999 | Undergraduate Discovery Science Experience in Renal Biology and Disease | 003 | 13 | NIH | 3/11/2024 | $92,896 |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | UM1AI069439 | Vanderbilt HIV Clinical Trials Unit (CTU) | 001 | 19 | NIH | 6/12/2024 | $329,389 |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | UM1AI069439 | Vanderbilt HIV Clinical Trials Unit (CTU) | 001 | 19 | NIH | 6/12/2024 | $995,361 |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | UM1AI069439 | Vanderbilt HIV Clinical Trials Unit (CTU) | 000 | 19 | NIH | 11/8/2023 | $329,390 |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | UM1AI069439 | Vanderbilt HIV Clinical Trials Unit (CTU) | 000 | 19 | NIH | 11/8/2023 | $995,361 |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DK093501 | WNK-SPAK signaling in the Distal Nephron | 000 | 14 | NIH | 6/21/2024 | $695,612 |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AR060846 | Revision ACL Reconstruction: A Comparative Effectiveness Treatment Study | 000 | 10 | NIH | 8/14/2024 | $699,945 |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | T32HS026122 | Learning Health System training program: PROgRESS-- Patient/ pRactice Outcomes and Research in Effectiveness and Systems Science | 002 | 7 | AHRQ | 6/26/2024 | $579,788 |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | T32AI095202 | Childhood Infections Research Program | 000 | 15 | NIH | 6/5/2024 | $322,401 |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | NU3HCK000006 | Enhanced Detection of Resistance, Antibiotic Stewardship and infection control, and Genome sequencing NETwork for AMR containment (DRAGNET) | 00 | 4 | CDC | 8/26/2024 | $100,000 |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | NU3HCK000006 | Enhanced Detection of Resistance, Antibiotic Stewardship and infection control, and Genome sequencing NETwork for AMR containment (DRAGNET) | 00 | 4 | CDC | 8/26/2024 | $100,000 |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01EY020894 | Targeting Tissue Biomechanics for Treatment of Glaucoma | 000 | 13 | NIH | 8/23/2024 | $456,985 |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | P01CA116087 | H. pylori-induced Inflammation and Gastric Cancer | 000 | 17 | NIH | 4/1/2024 | $1,723,815 |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01HL094786 | Outcome Dependent Sampling of Longitudinal Data: Design and Analysis | 001 | 10 | NIH | 6/24/2024 | $55,247 |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01HL094786 | Outcome Dependent Sampling of Longitudinal Data: Design and Analysis | 000 | 10 | NIH | 4/25/2024 | $621,539 |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | T32HL094296 | Interdisciplinary Training Program in Lung Research | 003 | 17 | NIH | 9/12/2024 | $413,798 |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AI077505 | Pharmacogenomics of HIV Therapy | 000 | 15 | NIH | 5/2/2024 | $814,885 |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | P30DK058404 | Molecular and Cellular Basis for Digestive Diseases | 002 | 23 | NIH | 6/21/2024 | $1,283,508 |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K12CA090625 | Vanderbilt Clinical Oncology Research Career Development Award | 000 | 24 | NIH | 6/11/2024 | $702,458 |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | T32AI007474 | Vanderbilt Infection Pathogenesis and Epidemiology Research Training Program | 000 | 30 | NIH | 7/25/2024 | $327,653 |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | T32CA106183 | Surgical Oncology Training Grant | 000 | 21 | NIH | 7/1/2024 | $359,995 |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | T32DK007569 | Renal Biology and Disease Training Program | 000 | 36 | NIH | 6/25/2024 | $353,350 |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | 90DDUC0077 | Vanderbilt Kennedy Center for Excellence in Developmental Disabilities | 00 | 5 | ACL | 6/26/2024 | $620,675 |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | P30CA068485 | Immune Landscape of Anal Cancer and Survival Outcomes in People with HIV (Immuno/Microenvironment) | 004 | 29 | NIH | 9/19/2024 | $0 |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | P30CA068485 | Immune Landscape of Anal Cancer and Survival Outcomes in People with HIV (Immuno/Microenvironment) | 003 | 29 | NIH | 9/4/2024 | $250,000 |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | P30CA068485 | Immune Landscape of Anal Cancer and Survival Outcomes in People with HIV (Immuno/Microenvironment) | 001 | 29 | NIH | 8/28/2024 | $7,263,544 |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | P30CA068485 | Immune Landscape of Anal Cancer and Survival Outcomes in People with HIV (Immuno/Microenvironment) | 002 | 29 | NIH | 9/3/2024 | $250,000 |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DK048370 | Small GTP Binding Proteins in Gastrointestinal Mucosa | 000 | 29 | NIH | 7/18/2024 | $590,663 |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | T32DK007061 | Research Training in Diabetes and Endocrinology | 000 | 51 | NIH | 6/21/2024 | $327,807 |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | U01AI069923 | Caribbean, Central, and South America network for HIV Epidemiology (CCASAnet) | 000 | 20 | NIH | 5/24/2024 | $284,212 |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | U01AI069923 | Caribbean, Central, and South America network for HIV Epidemiology (CCASAnet) | 000 | 20 | NIH | 5/24/2024 | $83,333 |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | U01AI069923 | Caribbean, Central, and South America network for HIV Epidemiology (CCASAnet) | 000 | 20 | NIH | 5/24/2024 | $76,814 |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | U01AI069923 | Caribbean, Central, and South America network for HIV Epidemiology (CCASAnet) | 000 | 20 | NIH | 5/24/2024 | $131,352 |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | U01AI069923 | Caribbean, Central, and South America network for HIV Epidemiology (CCASAnet) | 000 | 20 | NIH | 5/24/2024 | $1,509,494 |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | U01AI069923 | Caribbean, Central, and South America network for HIV Epidemiology (CCASAnet) | 000 | 20 | NIH | 5/24/2024 | $76,813 |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | U01AI069923 | Caribbean, Central, and South America network for HIV Epidemiology (CCASAnet) | 000 | 20 | NIH | 5/24/2024 | $153,628 |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | U01AI069923 | Caribbean, Central, and South America network for HIV Epidemiology (CCASAnet) | 000 | 20 | NIH | 5/24/2024 | $23,073 |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | U01AI069923 | Caribbean, Central, and South America network for HIV Epidemiology (CCASAnet) | 000 | 20 | NIH | 5/24/2024 | $750,000 |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | T32DK007673 | Training in Gastroenterology | 000 | 32 | NIH | 6/20/2024 | $438,032 |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DK051610 | Structure-function analysis of the volume-regulated anion channel VRAC using novel LRRC8 chimeras | 000 | 29 | NIH | 7/15/2024 | $474,220 |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | T35DK007383 | Vanderbilt Student Research Training Program | 003 | 45 | NIH | 5/10/2024 | $181,470 |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | T32GM007569 | Clinical Pharmacology Training Program | 000 | 49 | NIH | 6/10/2024 | $760,588 |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | T32HL087738 | Clinical and Translational Training Program in Pulmonary Medicine | 000 | 19 | NIH | 9/12/2024 | $478,860 |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | U19AI095227 | Viral and Host Determinants of Infant and Childhood Allergy and Asthma | 004 | 15 | NIH | 8/27/2024 | -$294,138 |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | U19AI095227 | Viral and Host Determinants of Infant and Childhood Allergy and Asthma | 004 | 15 | NIH | 8/27/2024 | $294,138 |
| 2024 | 2024 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | U19AI095227 | Viral and Host Determinants of Infant and Childhood Allergy and Asthma | 000 | 15 | NIH | 6/12/2024 | $1,526,769 |
|